Eingeschlossene Patienten: 22.854 (Stand 01. Juli 2024)
Amgevita® (Adalimumab)
223
Benepali® (Etanercept)
1199
Cimzia® (Certolizumab)
1028
Enbrel® (Etanercept)
2872
Erelzi® (Etanercept)
538
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
3
Hulio® (Adalimumab)
246
Humira® (Adalimumab)
2909
Hyrimoz® (Adalimumab)
219
Idacio® (Adalimumab)
62
Imraldi® (Adalimumab)
219
Inflectra™ (Infliximab)
17
Jyseleca® (Filgotinib)
141
Kevzara® (Sarilumab)
219
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
78
Olumiant® (Baricitinib)
538
Orencia® (Abatacept)
976
Remicade® (Infliximab)
762
Remsima® (Infliximab)
22
Rinvoq® (Upadacitinib)
305
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1374
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
469
Truxima® (Rituximab)
2
Tyenne® (Tocilizumab)
10
Xeljanz® (Tofacitinib)
396
Yuflyma® (Adalimumab)
29
Zessly® (Infliximab)
2
Kontrollen
6417
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok